Valorisation of stachysetin from cultivated Stachys iva Griseb. as anti-diabetic agent: a multi-spectroscopic and molecular docking approach

Abstract

Stachys species are considered as important medicinal plants with numerous health benefit effects. In continuation of our research on the Greek Stachys species, the chemical profile of the aerial parts of cultivated S. iva Griseb. has been explored. The NMR profiles of the plant extract/infusion were used to guide the isolation process, leading to the targeted isolation of seventeen known compounds. The rare acylated flavonoid, stachysetin, was isolated for the third time from plant species in the international literature. Identification of the characteristic signals of stachysetin in the 1D ¹H-NMR spectrum of the crude extract was presented. In order to evaluate the potential of the identified chemical space in Stachys to bear possible bioactivity against diabetes, we performed an in silico screening against 17 proteins implicated in diabetes, as also ligand based similarity metrics against established anti-diabetic drugs. The results capitalized the anti-diabetic potency of stachysetin. Its binding profile to the major drug carrier plasma protein serum albumin was also explored along with its photophysical properties suggesting that stachysetin could be recognized and delivered in plasma through serum albumin and also could be tracked through near-infrared imaging.

Communicated by Ramaswamy H. Sarma

Keywords:

• Stachysetin
• NMR
• in silico docking
• ligand based screening
• anti-diabetic activity

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

The project/research is co-financed by the European Regional Development Fund (ERDF) under the Operational Program "Epirus 2014-2020", NSRF 2014-2020 [ACRONYM: EPIRUSCOSMECEUTICALS, Grant Number: 5033143]